How to Chronic cerebral ischemia?

An application of the pueraria flavone in preparing the medicines for treating chronic cerebral ischemia is disclosed. Its preparing process includes such steps as providing pueraris roots, extracting in water or alcohol, concentrating, depositing in alcohol, purifying by chromatography, eluting and spray drying.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing notoperygium root in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872214ACardiovascular disorderPlant ingredientsMedicineChronic insufficiency

An application of the medicinal composition composed of 13 Chinese-medicinal materials including notopterygium root, Chuan-xiong rhizome, peach kernel, safflower, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing astragalus root in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872187AAnthropod material medical ingredientsCardiovascular disorderChronic insufficiencyChronic venous insufficiency

An application of the medicinal composition composed of 18 Chinese-medicinal materials including Chinese angelica root, astragalus root, red peony root, Chuan-xiong rhizome, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing uncaria in preparing medicine for treating insufficiency of blood supply for brain

InactiveCN1872291ANervous disorderCardiovascular disorderGastrodiaTraditional medicine

An application of the medicinal composition composed of 11 Chinese-medicinal materials including gastrodia tuber, uncaria stem with hooks, scutellaria root, capejasmine, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing giant typhonium tuber in preparing medicine for treating insufficiency of blood supply for brain

InactiveCN1872328ANervous disorderHydroxy compound active ingredientsGastrodiaMedicine

An application of the medicinal composition composed of 11 Chinese-medicinal materials including Chuan-xiong rhizome, red sage root, gastrodia tuber, borneol, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of extractive of ginkgo leaf in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872100AGinkgophyta medical ingredientsCardiovascular disorderChronic insufficiencyGinkgo biloba

An application of the gingko leaf's extract (pueraria flavone) in preparing the medicine for treating chronic cerebral ischemia is disclosed. A process for preparing said pueraria flavone is also disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing astragalus root in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872187BAnthropod material medical ingredientsCardiovascular disorderSalvia miltiorrhizaMedicine

View all

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing extractive of astragalus root in preparing medicine for treating insufficiency of blood supply for brain

InactiveCN1872276ACardiovascular disorderPlant ingredientsAnemarrhena asphodeloidesChronic cerebral ischemia

An application of the medicinal composition composed of astragalus root and anemarrhena rhizome in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing caltrop in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872145ACardiovascular disorderPlant ingredientsTribulus terrestrisChronic insufficiency

An application of the medicinal composition composed of Chuan-xiong rhizome, pueraria root and puncturevine caltrop in preparing the medicine for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication compositiioon of Guangdong date in preparing medicine for treating chronic insufficiency of blood supply for brain

InactiveCN1872297AHydroxy compound active ingredientsCardiovascular disorderSalvia miltiorrhizaMedicine

An application of the medicinal composition composed of auxiliary choerosponidas fruit, red sage root, cloves, borneol, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of catalpol and retinoic acid medicine composition in preparing medicine used for preventing or treating white matter damage

InactiveCN103316027ANo side effectsNervous disorderHydroxy compound active ingredientsReduced white matterAdditive ingredient

The invention belongs to the field of medicine, and relates to the field of medicine preparation treatment activity. The invention specifically relates to a catalpol and retinoic acid medicine composition CAT-RA and an application thereof in preparing medicines used for preventing and treating with white matter damage after chronic cerebral ischemia. As a result of experiments of CAT-RA in cells and in chronic cerebral ischemia disease animal models, CAT-RA assists in reducing brain tissue inflammatory responses after brain damage, reducing white matter pathological changes, inhibiting oligodendrocyte apoptosis and myelin damage in white matters, and promoting oligodendrocyte precursor cell differentiation and maturation. CAT-RA has the effects of protecting white matters and promoting white matter remyelination. Therefore, CAT-RA can be used as an active component for preparing medicines used for preventing and treating white matter damage after chronic cerebral ischemia, and can also be used for preparing medicines used for treating other cerebral vascular related diseases characterized in white matter damages. The invention provides a novel solution for prevention and treatment of white matter damage related diseases.

Application of catalpol and retinoic acid medicine composition in preparing medicine used for preventing or treating white matter damage

View all

Owner:ARMY MEDICAL UNIV

Application of medication composition of containing corydalis tuber in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872170ACardiovascular disorderPlant ingredientsChronic insufficiencyChronic venous insufficiency

An application of the medicinal composition composed of corydalis tube, northern siphonostegia, fortume's drynaria rhizome and ginseng in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Diagnostic reagent kit for detecting chronic brain pathologies of ischemic genesis

ActiveUS10408829B2Facilitate subsequent detectionHigh affinityDisease diagnosisCarrier-bound/immobilised peptidesGeneral practionerBrain pathologies

The invention relates to diagnostics, namely to a reagent kit, a rapid method and a device for detecting the fact of chronic, ischemia-linked brain pathology. A special feature of the invention is the use of an immunoactive hybrid peptide produced as a product of two fragments of the NMDA neuroreceptor subunits. A device is described that allows quick and convenient testing of autoantibodies in the patient's blood that recognize the hybrid peptide. The method of detection of autoantibodies is based on the principle of lateral flow immunochromatography. The invention can be used for prophylactic medical examination (screening of chronic ischemia-linked brain lesions), to detect decompensated chronic cerebral ischemia at the prehospital stage by general practitioners or neurologists, as well as in neurosurgery and sports medicine for diagnostics of delayed cerebral ischemia in persons with craniocerebral injury.

Diagnostic reagent kit for detecting chronic brain pathologies of ischemic genesis

View all

Owner:OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU DRD

Application of medication composition of containing extractive of astragalus root in preparing medicine for treating insufficiency of blood supply for brain

InactiveCN1872276BCardiovascular disorderPlant ingredientsAnemarrhena asphodeloidesAnemarrhena

An application of the medicinal composition composed of astragalus root and anemarrhena rhizome in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Application of medication composition of containing extractive of astragalus root in preparing medicine for treating insufficiency of blood supply for brain

View all

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing white peony root in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872178BCardiovascular disorderPlant ingredientsChronic insufficiencyChronic venous insufficiency

An application of the medicinal composition composed of ginseng and white peony root in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Application of medication composition of containing white peony root in preparing medication for treating chronic insufficiency of supplying blood for brain

View all

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing oil of dalbergia wood in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872157ACardiovascular disorderPlant ingredientsChronic insufficiencyChronic venous insufficiency

An application of the medical composition composed of red sage root, notoginseng and dalbergia wool oil in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing Gardenia in preparing medicine for treating chronic cerebral circulation insufficin

InactiveCN100563702CNervous disorderAnthropod material medical ingredientsGardeniaTraditional medicine

An application of the medicinal composition composed of 14 Chinese-medicinal materials including capejasmine fruit, rhubarb, coix seed, earthworm, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Application of medication composition of containing Gardenia in preparing medicine for treating chronic cerebral circulation insufficin

View all

Owner:TIANJIN TASLY PHARMA CO LTD

Use of medicinal composition containing red paeony root for preparing medicinefor treating chronic blood shortage to brain

InactiveCN1891263AAnthropod material medical ingredientsHydroxy compound active ingredientsMedicineSurgery

The present invention relates to a medicine composition and its application in preparation of medicine for curing chronic cerebral ischemia. Said medicine composition includes 8 Chinese medicinal materials of 10-20 portions of ginseng, 5-15 portions of red peony root, 6-15 portions of centipede, 10-20 portions of scorpion, 20-30 portions of leech, 10-20 portions of wingless cockroach, 10-20 portions of cicada molting and 2-10 portions of borneol.

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing giant typhonium tuber in preparing medicine for treating insufficiency of blood supply for brain

InactiveCN100548362CNervous disorderHydroxy compound active ingredientsGastrodiaPlant Tubers

View all

Owner:TIANJIN TASLY PHARMA CO LTD

Application of medication composition of containing BV6 in preparing medication for treating chronic insufficiency of supplying blood for brain

InactiveCN1872113AOrganic active ingredientsNervous disorderChronic insufficiencyChronic venous insufficiency

An application of the medicinal composition composed of Naoyiqin, the extract of notoginseng, VB6 and VE in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Owner:TIANJIN TASLY PHARMA CO LTD

A neural network-based cerebral ischemia risk prediction platform

ActiveCN114628036BTimely rescueLife in timeImage enhancementMedical imagingRadiologyBrain magnetic resonance

The invention relates to a neural network-based cerebral ischemia risk estimation platform, which comprehensively considers carotid plaque data and brain magnetic resonance images. ) and obviously abnormal plaques (high risk), leaving carotid plaques that are not easy to judge without obvious stenosis, and then use brain magnetic resonance images to break the conventional perception of carotid plaques themselves. Research to explore the relationship between plaque and brain structure, based on neural network modules, can predict carotid plaques from the initial changes of the brain, and estimate the level of cerebral ischemia risk, which can be used for the assessment of cerebral ischemia risk. It is used for the prediction and prevention of acute stroke, chronic cerebral ischemia, vascular dementia, etc. It is used for clinical prediction. It has a very positive effect on prevention before it occurs. It can improve the accuracy of diagnosis and save the disease to a greater extent and in a timely manner. suffer from life.